Research Reports
- 11/16/2020
3Q: Cost reduced, Revenue Generation Continues
- 7/14/2020
gammaCore Becomes the 1st Approved Medical Device to Treat Coronavirus-related Breathing Difficulty
- 5/19/2020
Q1 2020: Progressing Slowly but Steady
- 3/30/2020
gammaCore Received Clearance for Prevention of Migraine
- 3/25/2020
Q4 2019 Results: Lagged Commercial Success
- 11/15/2019
Q3 2019: Revising Outlook After Slow Quarter
- 10/2/2019
What do the recent developments mean for electroCore?
- 8/15/2019
Soothing Investors’ Migraine a Bit?
- 8/14/2019
Soothing Investors’ Migraine a Bit?
- 6/11/2019
Choppy Waters for electroCore
- 6/4/2019
Continuing Execution of the Redeployment Plan
- 5/31/2019
Can the Reduced Cash Burn Calm Ragged Nerves?